We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Breakthrough Blood Test Developed For Schizophrenia Predicts Most Effective Treatments

By LabMedica International staff writers
Posted on 12 Feb 2024
Print article
Image: A new blood test predicts psychosis risk and the most effective treatments (Photo courtesy of 123RF)
Image: A new blood test predicts psychosis risk and the most effective treatments (Photo courtesy of 123RF)

Millions of people worldwide are affected by psychotic disorders, with psychosis typically emerging in young adulthood — a crucial phase of life. Stress and substance use, including marijuana, can trigger psychosis in individuals with a genetic predisposition. Without intervention, psychosis can lead to escalating biological, social, and psychological harm. Schizophrenia, a psychiatric condition characterized by hallucinations and delusions, is challenging to diagnose, particularly in its early stages. It is crucial to match individuals with the most effective treatment from the outset. Now, a new test developed for schizophrenia is capable of identifying biomarkers in a person's blood. This test objectively evaluates their current severity and future risk for the disorder and aligns them with treatments that are most suitable for their unique biological makeup.

In a study, a team of researchers led by Indiana University School of Medicine (Indianapolis, IN, USA) observed psychiatric patients for over a decade. The team identified biomarkers indicative of high hallucination and delusion states, as well as those predictive of future psychiatric hospitalizations related to these symptoms. They also determined which biomarkers are affected by existing drugs, facilitating the alignment of patients with appropriate treatments. This research builds upon two decades of work by the team on blood biomarkers for various psychiatric conditions, including mood disorders, anxiety, post-traumatic stress disorder, suicidality risk, pain, and memory disorders. Notably, the identified biomarkers were found to be more predictive than standard evaluation scales for hallucinations and delusions. This implies that the biomarker test can help minimize subjectivity and uncertainty in psychiatric assessments. The test is expected to be commercially available later this year.

Related Links:
Indiana University School of Medicine

Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Histamine ELISA
Histamine ELISA
New
FLU/RSV Test
Humasis FLU/RSV Combo

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.